This study aimed to investigate the potential application of plasma signal peptide‐complement C1r/C1s, Uegf and Bmp1‐epidermal growth factor domain‐containing protein 1 (SCUBE‐1) as a biomarker in the diagnosis of pulmonary embolism (PE). This evidence concerns the gene SCUBE1 and pulmonary embolism.